In ovarian cancer patients, the PLK1-positive cell population also increased with cancer stage: 14.74 ± 5.81%, 23.00 ± 9.610%, and 32.55 ± 9.36% in stages 1, 2, and 3, respectively53. This evidence concerns the gene PLK1 and ovarian cancer.